Skip to main content
. 2021 Aug 10;13(8):1232. doi: 10.3390/pharmaceutics13081232

Table 2.

Effect of the γ-Fe2O3, and (γ-Fe2O3/PLGA)/CS NPs on haemolysis (%), complement activation (C3a release: C3a desArg, ng/mL), platelet activation (sP-selectin release, ng/mL), and plasma recalcification time (T1/2 max, min). Data is indicated as means ± SDs (n = 3).

γ-Fe2O3 NPs (γ-Fe2O3/PLGA)/CS NPs Control (PBS Solution)
Haemolysis (%) 1.6 ± 0.1 2.5 ± 0.4 0
C3a desArg (ng/mL) 296 ± 3 309 ± 8 290 ± 9
sP-selectin release (ng/mL) 105 ± 6 117 ± 5 99 ± 6
T1/2 max (min) 14.1 ± 0.7 13.8 ± 1.2 12.2 ± 0.9